Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study

Medicine, Bevacizumab, Internal medicine, Colorectal cancer, Oncology, Proportional hazards model, Hazard ratio, KRAS, Univariate analysis, Obesity, Chemotherapy, Progression-free survival, Cancer, Multivariate analysis